BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29668871)

  • 1. Transgenic Mice Overexpressing SREBP-1a in Male ob/ob Mice Exhibit Lipodystrophy and Exacerbate Insulin Resistance.
    Ohno H; Matsuzaka T; Tang N; Sharma R; Motomura K; Shimura T; Satoh A; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Nakagawa Y; Sone H; Yahagi N; Yamada N; Higami Y; Shimano H
    Endocrinology; 2018 Jun; 159(6):2308-2323. PubMed ID: 29668871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice.
    Yahagi N; Shimano H; Hasty AH; Matsuzaka T; Ide T; Yoshikawa T; Amemiya-Kudo M; Tomita S; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Osuga J; Harada K; Gotoda T; Nagai R; Ishibashi S; Yamada N
    J Biol Chem; 2002 May; 277(22):19353-7. PubMed ID: 11923308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.
    Shimomura I; Matsuda M; Hammer RE; Bashmakov Y; Brown MS; Goldstein JL
    Mol Cell; 2000 Jul; 6(1):77-86. PubMed ID: 10949029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mice overexpressing SREBP-1a under the control of the PEPCK promoter exhibit insulin resistance, but not diabetes.
    Takahashi A; Shimano H; Nakagawa Y; Yamamoto T; Motomura K; Matsuzaka T; Sone H; Suzuki H; Toyoshima H; Yamada N
    Biochim Biophys Acta; 2005 Jun; 1740(3):427-33. PubMed ID: 15949711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and adipose tissue macrophages in lipodystrophic mice.
    Herrero L; Shapiro H; Nayer A; Lee J; Shoelson SE
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):240-5. PubMed ID: 20007767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1.
    Jong MC; Voshol PJ; Muurling M; Dahlmans VE; Romijn JA; Pijl H; Havekes LM
    Diabetes; 2001 Dec; 50(12):2779-85. PubMed ID: 11723061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
    Wada T; Miyashita Y; Sasaki M; Aruga Y; Nakamura Y; Ishii Y; Sasahara M; Kanasaki K; Kitada M; Koya D; Shimano H; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1415-25. PubMed ID: 24129399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new transgenic rat model of hepatic steatosis and the metabolic syndrome.
    Qi NR; Wang J; Zidek V; Landa V; Mlejnek P; Kazdová L; Pravenec M; Kurtz TW
    Hypertension; 2005 May; 45(5):1004-11. PubMed ID: 15809359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.
    Sekiya M; Yahagi N; Matsuzaka T; Najima Y; Nakakuki M; Nagai R; Ishibashi S; Osuga J; Yamada N; Shimano H
    Hepatology; 2003 Dec; 38(6):1529-39. PubMed ID: 14647064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy.
    Kralisch S; Hoffmann A; Estrada-Kunz J; Stumvoll M; Fasshauer M; Tönjes A; Miehle K
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003626
    [No Abstract]   [Full Text] [Related]  

  • 12. Inactivation of SREBP-1a Phosphorylation Prevents Fatty Liver Disease in Mice: Identification of Related Signaling Pathways by Gene Expression Profiles in Liver and Proteomes of Peroxisomes.
    Knebel B; Hartwig S; Jacob S; Kettel U; Schiller M; Passlack W; Koellmer C; Lehr S; Müller-Wieland D; Kotzka J
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
    Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
    Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
    Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
    Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterol regulatory element-binding protein-1c orchestrates metabolic remodeling of white adipose tissue by caloric restriction.
    Fujii N; Narita T; Okita N; Kobayashi M; Furuta Y; Chujo Y; Sakai M; Yamada A; Takeda K; Konishi T; Sudo Y; Shimokawa I; Higami Y
    Aging Cell; 2017 Jun; 16(3):508-517. PubMed ID: 28256090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.
    VerHague MA; Cheng D; Weinberg RB; Shelness GS
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2501-8. PubMed ID: 24030551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.
    Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY
    Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipogenic SREBP-1a/c transcription factors activate expression of the iron regulator hepcidin, revealing cross-talk between lipid and iron metabolisms.
    Xiaoli AM; Song Z; Yang F
    J Biol Chem; 2019 Aug; 294(34):12743-12753. PubMed ID: 31270208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.
    Shimomura I; Hammer RE; Richardson JA; Ikemoto S; Bashmakov Y; Goldstein JL; Brown MS
    Genes Dev; 1998 Oct; 12(20):3182-94. PubMed ID: 9784493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.